Amundi - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 48 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Amundi ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$184,500
-59.8%
200,000
-60.0%
0.00%
Q4 2022$458,750
-0.1%
500,0000.0%0.00%
Q3 2022$459,000
+4.3%
500,0000.0%0.00%
Q2 2022$440,000
-2.9%
500,0000.0%0.00%
Q1 2022$453,0000.0%500,0000.0%0.00%
Q4 2021$453,000
-0.7%
500,0000.0%0.00%
Q3 2021$456,000500,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 44,079,000$39,875,0002.95%
Opti Capital Management, LP 42,438,000$38,379,0002.91%
DeepCurrents Investment Group LLC 72,004,000$64,996,0002.02%
TENOR CAPITAL MANAGEMENT Co., L.P. 64,271,000$58,076,0001.21%
CAMDEN ASSET MANAGEMENT L P /CA 24,846,000$22,206,0000.83%
Penn Mutual Asset Management 856$765,0000.82%
Context Capital Management, LLC 7,848$7,087,0000.55%
SHENKMAN CAPITAL MANAGEMENT INC 4,903,000$4,362,0000.30%
AQR Arbitrage LLC 9,425,000$8,471,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 19,075,000$17,143,0000.19%
View complete list of IONIS PHARMACEUTICALS INC shareholders